The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 4×
“Cell line transfection and selection The ability to produce and select for a high-producing animal cell line is key to the initial stages of the development of a cell culture bioprocess (Wurm 2004; Andersen and Krummen 2002).”
BackgroundInfluentialShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835 · cited 2×
“The presence of a bisecting N-acetylglucosamine (Umana et al. 1999; Davies et al. 2001) or the absence of fucose (Shields et al. 2002; Shinkawa et al. 2003; Okazaki et al. 2004) in the conserved glycan of an IgG antibody has been shown to enhance attachment to Fc receptors and result in an increase…”
BackgroundShinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413 · cited 3×
“The presence of a bisecting N-acetylglucosamine (Umana et al. 1999; Davies et al. 2001) or the absence of fucose (Shields et al. 2002; Shinkawa et al. 2003; Okazaki et al. 2004) in the conserved glycan of an IgG antibody has been shown to enhance attachment to Fc receptors and result in an increase…”
BackgroundUmaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764 · cited 3×
“The presence of a bisecting N-acetylglucosamine (Umana et al. 1999; Davies et al. 2001) or the absence of fucose (Shields et al. 2002; Shinkawa et al. 2003; Okazaki et al. 2004) in the conserved glycan of an IgG antibody has been shown to enhance attachment to Fc receptors and result in an increase…”
BackgroundTherapeutic antibodies for human diseases at the dawn of the twenty-first century
Brekke, O. H., & Sandlie, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd984 · Cited by 550
Bebbington, C. R., Renner, G., Thomson, S., King, D., Abrams, D., & Yarranton, G. T. (1992) · Nature Biotechnology · doi:10.1038/nbt0292-169 · Cited by 462
Getting the glycosylation right: Implications for the biotechnology industry
Jenkins, N., Parekh, R. B., & James, D. C. (1996) · Nature Biotechnology · doi:10.1038/nbt0896-975 · Cited by 458
Raju, T. S., Briggs, J. B., Borge, S. M., & Jones, A. J. S. (2000) · Glycobiology · doi:10.1093/glycob/10.5.477 · Cited by 452
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo
Erbayraktar, S., Grasso, G., Sfacteria, A., Xie, Q.-W., Coleman, T., Kreilgaard, M., Torup, L., Sager, T., Erbayraktar, Z., Gokmen, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031753100 · Cited by 436
Egrie, J. C., Dwyer, E., Browne, J. K., Hitz, A., & Lykos, M. A. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00006-7 · Cited by 421
Cited by
Post-translational modifications in the context of therapeutic proteins
Walsh, G., & Jefferis, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1252 · Cited by 1,005
Cell culture processes for monoclonal antibody production
Li, F., Vijayasankaran, N., Shen, A. (., Kiss, R., & Amanullah, A. (2010) · mAbs · doi:10.4161/mabs.2.5.12720 · Cited by 739
Mammalian cell protein expression for biopharmaceutical production
Zhu, J. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.08.022 · Cited by 491
Advances in measuring cellular bioenergetics using extracellular flux
Ferrick, D. A., Neilson, A., & Beeson, C. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.12.008 · Cited by 460
Roadmap for implementation of quality by design (QbD) for biotechnology products
Rathore, A. S. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.06.006 · Cited by 411
Biopharmaceutical benchmarks 2006
Walsh, G. (2006) · Nature Biotechnology · doi:10.1038/nbt0706-769 · Cited by 359
Expression of Recombinant Antibodies
Frenzel, A., Hust, M., & Schirrmann, T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00217 · Cited by 353
The art of CHO cell engineering: A comprehensive retrospect and future perspectives
Fischer, S., Handrick, R., & Otte, K. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.015 · Cited by 312
The Translation of Cell-Based Therapies: Clinical Landscape and Manufacturing Challenges
Heathman, T. R., Nienow, A. W., McCall, M. J., Coopman, K., Kara, B., & Hewitt, C. J. (2015) · Regenerative Medicine · doi:10.2217/rme.14.73 · Cited by 297
Eid, R., Arab, N. T. T., & Greenwood, M. T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.12.002 · Cited by 288
O’Flaherty, R., Bergin, A., Flampouri, E., Mota, L. M., Obaidi, I., Quigley, A., Xie, Y., & Butler, M. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107552 · Cited by 277
Self-citationRitacco, F. V., Wu, Y., & Khetan, A. (2018) · Biotechnology Progress · doi:10.1002/btpr.2706 · Cited by 273
Grillberger, L., Kreil, T. R., Nasr, S., & Reiter, M. (2009) · Biotechnology Journal · doi:10.1002/biot.200800241 · Cited by 144
Corchero, J. L., Gasser, B., Resina, D., Smith, W., Parrilli, E., Vázquez, F., Abasolo, I., Giuliani, M., Jäntti, J., Ferrer, P., et al. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.001 · Cited by 133
Metabolic responses of CHO cells to limitation of key amino acids
Duarte, T. M., Carinhas, N., Barreiro, L. C., Carrondo, M. J. T., Alves, P. M., & Teixeira, A. P. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25266 · Cited by 110
Jedrzejczak-Silicka, M. (2017) · New Insights into Cell Culture Technology · doi:10.5772/66905 · Cited by 87
Doolan, P., Meleady, P., Barron, N., Henry, M., Gallagher, R., Gammell, P., Melville, M., Sinacore, M., McCarthy, K., Leonard, M., et al. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22670 · Cited by 84
Park, J. H., Noh, S. M., Woo, J. R., Kim, J. W., & Lee, G. M. (2016) · Biotechnology Journal · doi:10.1002/biot.201500327 · Cited by 81
Xing, Z., Li, Z., Chow, V., & Lee, S. S. (2008) · Biotechnology Progress · doi:10.1021/bp070466m · Cited by 52
Wang, Z., Park, J. H., Park, H. H., Tan, W., & Park, T. H. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23091 · Cited by 50
Onitsuka, M., Kim, W.-D., Ozaki, H., Kawaguchi, A., Honda, K., Kajiura, H., Fujiyama, K., Asano, R., Kumagai, I., Ohtake, H., et al. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3814-1 · Cited by 48
Autophagy and its implication in Chinese hamster ovary cell culture
Kim, Y. J., Baek, E., Lee, J. S., & Lee, G. M. (2013) · Biotechnology Letters · doi:10.1007/s10529-013-1276-5 · Cited by 40
Picanco-Castro, V., Biaggio, R., Cova, D., & Swiech, K. (2013) · Protein & Peptide Letters · doi:10.2174/092986652012131112130322 · Cited by 34
Rahimpour, A. (2013) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1302.02035 · Cited by 30
Yun, C. Y., Liu, S., Lim, S. F., Wang, T., Chung, B. Y. F., Jiat Teo, J., Chuan, K. H., Soon, A. S. C., Goh, K. S., & Song, Z. (2007) · Metabolic Engineering · doi:10.1016/j.ymben.2007.06.001 · Cited by 30
Zhuang, C., Zheng, C., Chen, Y., Huang, Z., Wang, Y., Fu, Q., Zeng, C., Wu, T., Yang, L., & Qi, N. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8312-7 · Cited by 16
Aghamohseni, H., Spearman, M., Ohadi, K., Braasch, K., Moo-Young, M., Butler, M., & Budman, H. M. (2017) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-017-1926-z · Cited by 13
Self-citation
Metadata
- Authors
- Butler, M.
- Venue
- Applied Microbiology and Biotechnology
- Published
- 2005-04-16
- Volume
- 68
- Issue
- 3
- Pages
- 283-291
- ISSN
- 0175-7598 (ISSN-L)
- 1432-0614
- OpenAlex
- W2069349248
- Cited by
- 469
- References
- 68
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.